已收盤 02-06 16:00:00 美东时间
+0.230
+0.13%
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
UBS analyst Batya Levi maintains SBA Communications (NASDAQ:SBAC) with a Buy and lowers the price target from $275 to $260.
01-21 04:00
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
今日重点评级关注:HC Wainwright & Co.:维持Enlivex Therapeutics"买入"评级,目标价从7美元升至13美元;BTIG:维持Oruka Therapeutics"买入"评级,目标价从63美元升至73美元
01-13 10:18
JP Morgan analyst Richard Choe maintains SBA Communications (NASDAQ:SBAC) with a Neutral and lowers the price target from $245 to $240.
01-13 03:55
The most oversold stocks in the real estate sector presents an opportunity to b...
01-12 19:41
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
2025-12-17 10:46
Wells Fargo analyst Eric Luebchow maintains SBA Communications (NASDAQ:SBAC) with a Equal-Weight and lowers the price target from $215 to $205.
2025-12-16 23:13
今日重点评级关注:RBC Capital:上调Neumora Therapeutics评级至"跑赢大市",目标价从4美元升至7美元;HC Wainwright & Co.:维持ProMIS Neurosciences"买入"评级,目标价从4美元升至18美元
2025-12-02 09:50
Barclays analyst Brendan Lynch maintains SBA Communications (NASDAQ:SBAC) with a Overweight and lowers the price target from $219 to $212.
2025-12-02 00:00